The meta-analysis evaluated the efficacy and safety of anti-IgE group compared with the control group across various outcomes, such as AER, asthma-related hospitalizations, FEV1, ACQ scores, AQLQ scores, AEs, and SAEs. The gene discussed is IGHE; the disease is asthma.